about
Insulin glulisine: a review of its use in the management of diabetes mellitusEltrombopag.Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopenia.Spotlight on eltrombopag in treatment-refractory chronic primary immune thrombocytopenia.Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia.Intranasal ketorolac: for short-term pain management.Ripasudil: first global approval.Vonoprazan: first global approval.Necitumumab: First Global Approval.Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males.Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com.Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.Caspofungin: in pediatric patients with fungal infections.Alitretinoin: in severe chronic hand eczema.Armodafinil.Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia.Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents.Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.Fospropofol.Methylnaltrexone.Ecallantide: in acute hereditary angioedema.Bendamustine: a review of its use in the management of indolent non-Hodgkin's lymphoma and mantle cell lymphoma.Escitalopram: a review of its use in the management of major depressive disorder in adults.Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.Azithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitis.Ranibizumab: in macular oedema following retinal vein occlusion.Dextromethorphan/quinidine: in pseudobulbar affect.Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension.Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures.Belatacept: in adult kidney transplant recipients.Boceprevir: a review of its use in the management of chronic hepatitis C genotype 1 infection.Brentuximab vedotin: a review of its use in patients with hodgkin lymphoma and systemic anaplastic large cell lymphoma following previous treatment failure.Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy.Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.Levomilnacipran extended release: first global approval.Teriflunomide: a review of its use in relapsing multiple sclerosis.Alemtuzumab: a review of its use in patients with relapsing multiple sclerosis.Diclofenac potassium powder for oral solution: a review of its use in patients with acute migraine.Vortioxetine: a review of its use in major depressive disorder.
P50
Q28247429-87C9B26C-3934-43C1-BB8E-9B497B8F6056Q33384108-45EF3941-1E65-46DF-8BF5-EBCF0BBF618FQ33396286-B0A51318-BEEC-4813-8365-957A44482C2AQ33397968-F4102AC6-CE28-4B45-8399-22D4A16BE71FQ33432023-23E72C31-9050-4FBD-BBF0-34A351DA319BQ34273964-21EEBACD-36EB-4A46-9CD0-440BC3656E06Q34448865-529B6E43-97A5-4E4E-9E4C-E1D9892FA630Q34465959-190CC1DF-BAF7-4E83-9DEF-22EC50CDA2EFQ35884714-C34FC986-24F5-427D-9CA0-255626F64263Q36270681-CE6B853B-9CFC-488D-896E-97A91EB5C140Q36649321-381923D9-B4F0-46A2-80EB-1066FFB60173Q37483892-627FB5B4-D860-452A-B339-E466634B7E9DQ37535951-8968152B-3D24-4E6C-8EEA-A2C0C0D8A354Q37579176-007ABD3E-42BF-45EA-9664-D637D0A55DD0Q37581591-3D1493A4-5D98-4167-BD02-ACEE25EF0C9BQ37605781-8CAA4826-69BF-4B76-98BF-D2B8E0212039Q37661482-829E15D4-A9E7-435E-A057-A80AD3E561AEQ37682882-59A6BAF8-A944-4A98-827B-343A827005E6Q37703197-9575CC02-ACDF-4C1F-BEE5-14FEB1C6BC48Q37738872-9496AAB8-80D1-4338-BC23-016992C0E632Q37771018-23975EEC-8479-47B2-86DA-3C8EB44937F1Q37781808-D26BA594-3CBD-415E-9FEA-E3EA6605B5B2Q37784204-F703F46E-4BBC-41C5-97D4-B2369F228AE6Q37832237-FC8A7E84-B335-4FCE-BA05-4AFB64532AFEQ37849348-1DDBBF12-D3A4-46D7-8CB6-1716966104CAQ37851955-0F7D17F6-4B62-4DB6-AC83-5943C9784480Q37863094-6B7684FB-F743-41EF-8396-80B81A57AF16Q37970761-552DD6E8-80B8-4E89-99FE-20E024ADE160Q38014475-91649A2C-CC79-4D3D-8058-F3394EFBB2FCQ38019029-81EAADDD-A506-4E87-B447-B002B8210F69Q38038669-3BDCD99D-3653-45BB-AFE8-3195D1858AE0Q38066535-EB9052BF-4A9B-4EB3-A154-BE253FFF3281Q38089624-CADDBA76-FAA1-43C3-836D-5AE2C76BEAAAQ38091673-CB9D510A-1F1F-4F40-879D-528CBD06479EQ38126369-A6A409B3-52BC-4C9A-A57F-5A6AEB83F611Q38133771-3AD1EB97-97AC-436A-9FB0-622D85B3D56CQ38160410-929A9FCF-6179-4A8C-84FB-FB6438570063Q38194115-D30964BF-AC71-43D6-BD4C-BD20F5F3B845Q38230717-D506D0FB-AEED-4EC3-88E2-671F2341D662Q38242001-CE2F0B04-E73D-41F9-9FDB-1871C837951A
P50
description
New Zealand medical writer
@en
escritora sobre medicina neozelandesa
@ast
medisch schrijfster uit Nieuw-Zeeland
@nl
name
Karly Garnock-Jones
@ast
Karly Garnock-Jones
@en
Karly Garnock-Jones
@es
Karly Garnock-Jones
@fr
Karly Garnock-Jones
@nl
Karly Garnock-Jones
@sl
type
label
Karly Garnock-Jones
@ast
Karly Garnock-Jones
@en
Karly Garnock-Jones
@es
Karly Garnock-Jones
@fr
Karly Garnock-Jones
@nl
Karly Garnock-Jones
@sl
altLabel
Karly P. Garnock-Jones
@en
Karly Philippa Garnock-Jones
@en
prefLabel
Karly Garnock-Jones
@ast
Karly Garnock-Jones
@en
Karly Garnock-Jones
@es
Karly Garnock-Jones
@fr
Karly Garnock-Jones
@nl
Karly Garnock-Jones
@sl
P950
P106
P108
P21
P214
2146822249107381873
P27
P31
P496
0000-0002-1109-9945
P7859
viaf-2146822249107381873